Contessa: A multinational, multicenter, randomized, phase 3 registration study of tesetaxel in patients (Pts) with HER2-, hormone receptor + (HR+) locally advanced or metastatic breast cancer (MBC) Meeting Abstract
| Authors: | O'Shaughnessy, J.; Piccart-Gebhart, M. J.; Schwartzberg, L. S.; Cortes, J.; Harbeck, N.; Im, S. A.; Rugo, H. S.; Untch, M.; Yardley, D. A.; Bondarenko, I.; Chan, S.; Dieras, V.; Gianni, L.; Pegram, M. D.; Kroll, S.; O'Connell, J. P.; Vacirca, J. L.; Wei, T.; Tang, K.; Seidman, A. D. |
| Abstract Title: | Contessa: A multinational, multicenter, randomized, phase 3 registration study of tesetaxel in patients (Pts) with HER2-, hormone receptor + (HR+) locally advanced or metastatic breast cancer (MBC) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 60s |
| Language: | English |
| ACCESSION: | WOS:000442916007523 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.TPS1106 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS1106 -- Source: Wos |
